Introduction {#s1}
============

Overweight/obesity has become a serious public health problem accompanying changes in dietary habits and physical activity and is increasing to epidemic proportions in most industrialized counties [@pone.0102589-Flegal1], [@pone.0102589-Kumanyika1]. Many in-depth studies have investigated the impacts of body weight on mortality. However, the elderly are frequently excluded from such studies, particularly those presenting with compromising comorbidities. Cardiovascular disease (CVD) represents the main cause of mortality in the elderly population; obesity is a significant risk factor for CVD and other CVD-related diseases such as hypertension, type II diabetes mellitus, and dyslipidemia [@pone.0102589-Lavie1],[@pone.0102589-Yazdanyar1]. Nevertheless, clarifying how overweight or obesity influences the survival of the elderly, including all-cause and CVD mortality, may be critical.

Numerous reports in the previous decade document an obesity paradox: overweight or obese individuals are reported to have a mortality risk lower than that of normal weight individuals [@pone.0102589-Artham1]--[@pone.0102589-Uretsky1]. This contradicts the well-accepted empirically based idea that obesity confers increased mortality. This controversy is frequently debated, and whether such findings can be applied to the elderly, which is the fastest growing population segment in many countries, remains inconclusive. Body mass index (BMI) is a reasonably good measure of general adiposity in the elderly [@pone.0102589-Kumanyika1]. The effects of increasing BMI on mortality are less pronounced in the elderly than young or middle-aged adults [@pone.0102589-Stevens1]. However, another study reports the obesity--mortality relationship strengthens with age after controlling for confounders [@pone.0102589-Masters1]. In 2006, Janssen et al. performed a meta-analysis examining the association between elevated BMI and all-cause mortality in the elderly; they report overweight is not associated with a significantly increased risk of mortality, while moderate obesity is associated with a modest increase in risk [@pone.0102589-Janssen1]. In contrast, in 2013, Flegal et al. performed another meta-analysis evaluating the associations of overweight and obesity with all-cause mortality in the elderly; they report overweight is associated with significantly lower mortality and obesity is not associated with higher mortality [@pone.0102589-Flegal2]. Meanwhile, Lin et al. report higher BMI and waist circumference are associated with lower mortality in Chinese long-term care facility residents [@pone.0102589-Lin1]. These contradictory findings may be attributable to the different follow-up periods and covariates analyzed [@pone.0102589-Flegal3]. Thus, the optimal BMI and effects of being underweight or overweight on the risk of mortality of the elderly remain controversial. Therefore, further evidence is needed to clarify this issue.

This study evaluated the associations of BMI with all-cause mortality, CVD mortality, and expanded CVD in a large cohort of elderly Taiwanese people, who were medically screened in a standardized process and followed-up for 5 years, yielding 254,211 person--years of observation. Expanded CVD was coined as a new category to capture additional deaths traditionally not classified as CVDs, such as diabetes and kidney diseases.

Methods {#s2}
=======

Study population {#s2a}
----------------

The main data were from the Taipei Geriatric Health Examination Database. The study cohort comprised 77,541 participants aged 65 years or older, including 39,365 men and 38,176 women, in a standard annular physical examination program for elderly people run by the Taipei City Government from 2006--2010. Identical screening procedures and protocol were used in all qualified hospitals that contracted with the Department of Health, Taipei City Government [@pone.0102589-Department1]. The results were centrally managed and stored. Subjects participated in the physical examination program voluntarily and were encouraged to visit on an annual basis. However, only the results from the initial visit were analyzed. Demographic and lifestyle information (e.g., marital status, education level, smoking history, alcohol consumption, and exercising habit) were collected through a self-administered questionnaire. During the medical check-up, blood pressure was measured. Overnight fasting blood was collected for the measurement of serum blood sugar, triglyceride (TG), total cholesterol (TC), glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), albumin, blood urine nitrogen (BUN), creatinine, and hemoglobin. Data related to individual identification were removed before all data were released to the researchers. The acquisition and processing of the data were approved by the Institutional Review Board of Taipei City Hospital (approval number: TCHIRB-1020417-E).

Definition of BMI {#s2b}
-----------------

Height and weight were measured during examinations using standardized procedures. BMI was calculated as weight in kilograms divided by height in meters squared. This study employed the BMI-based categories defined by the World Health Organization (WHO) of underweight (BMI\<18.5), normal weight (18.5≤BMI\<25, reference category), overweight (25≤BMI\<30), grade 1 obesity (30≤BMI\<35), and grade 2--3 obesity (BMI≥35).

Controlled variables {#s2c}
--------------------

Baseline data were collected, including age (i.e., 65--69, 70--74, 75--79, 80--84, or ≥85 years), sex, marital status (i.e., single, married/cohabiting), education level (i.e., none, 1--6 years, 7--12 years, or \>12 years), smoking (i.e., frequently/occasionally or no), alcohol consumption (i.e., frequently/occasionally or no), and regular exercise (i.e., none, 1--2 times/week, or 3--5 times/week), high fasting blood sugar (FBS) (i.e., no or ≥126 mg/dL), high systolic blood pressure (SBP) (i.e., no or ≥140 mmHg), high TG (i.e., no or ≥200 mg/dL), and high TC (i.e., no or ≥200 mg/dL).

Outcome variables {#s2d}
-----------------

The vital status of the 77,541 study subjects as of December 31, 2010 was ascertained by matching cohort IDs with computerized national death files. Information on the causes of death was coded according to the International Classification of Diseases, Ninth Revision (ICD-9) 2006 or ICD-10 2009 and 2010, including all causes (ICD-9: 001--998; ICD-10: A00-Z99), CVDs (ICD-9: 390--459; ICD-10: I00--I99), and expanded CVD (CVD plus diabetes, ICD-9: 250; ICD-10: E10--E14, plus kidney diseases, ICD-9: 580--589; ICD-10: N00--N29).

Statistical analyses {#s2e}
--------------------

The relative risks of all-cause, CVD, and expanded CVD mortality were calculated using Cox proportional hazards models. The proportional hazard assumption was examined by plotting the log-log plots of each category of BMI, and the plot showed that the line for each category was straight and parallel. We also tested whether the log hazard ratio function is constant over time. For 19 of the 21 variables, we accepted the null hypothesis, and for 2 variables, we rejected the null hypothesis, i.e., exercise for 3--5 times/week (*P*\<0.001) and BMI of 25--29.9 kg/m^2^ (*P* = 0.03). The log-log plots indicated that the data might be suitable for the Weibull distribution parameters estimation. A sensitivity test of the Weibull model was performed. The times of entry and exit were the date of examination and the end of follow-up (December 31, 2010) or death if earlier, respectively. The reference group comprised subjects with 18.5≤BMI\<25, and the hazard ratio (HR) for each BMI category was calculated. Two models were used to avoid over-adjusting for factors in the causal relationship between obesity and mortality. The first model was adjusted for age, sex, marital status, education level, smoking, alcohol consumption, and physical activity; models adjusted for these factors are considered to be adequately adjusted [@pone.0102589-Flegal2]. Additional variables closely related to metabolic syndrome, including high FBS, high SBP, high TG, and high TC, were adjusted for in the second model, which was considered an over-adjusted model. Furthermore, the HRs were calculated with grades 1 and 2--3 obesity combined as a single obesity group. Another sensitivity test was performed to calculate the HR with the reference group set as subjects with 23≤BMI\<25.

In the model considered adequately adjusted, HRs were calculated for the following specific subgroups: non-smokers, smokers, men, women, young--old (65--74 years), old--old (≥75 years), normal FBS, high FBS (≥126 mg/dL), normal SBP, high SBP (≥140 mmHg), normal TG, high TG (≥200 mg/dL), normal TC, and high TC (≥200 mg/dL) as well as and 0, 1, 2, or 3--4 risk factors for metabolic syndrome (i.e., high FBS, high SBP, high TG, and high TG).

All analyses were performed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA) and the STATA 10.0 (STATA Corp, College Station, TX, USA). The level of significance was set at *P*\<0.05.

Results {#s3}
=======

The percentages of individuals in each BMI category, selected characteristics of all individuals, and mortality during follow-up are shown in [Table 1](#pone-0102589-t001){ref-type="table"}. The mean ± SD age of participants was 73.1±6.6 years. The 5-year study period yielded 254,211 person-years of follow-up, with a mean follow-up of 3.3±1.3 years. According to the WHO definition, the BMI of 3.5%, 57.8%, 33.4%, 4.8%, and 0.5% of the elderly population was classified as underweight, normal weight, overweight, grade 1 obesity, and grade 2--3 obesity, respectively. During the 5 years of follow-up, 3,842 (5.0%) deaths occurred, including 877 (22.8% of all deaths) deaths due to CVD and 1,116 (29.0%) deaths due to expanded CVD. Among all participants, 9,923 (12.8%), 30,745 (39.6%), 9,349 (12.1%), and 36,919 (47.6%) had high FBS, SBP, TG, and TC, respectively; 57,166 (73.7%) had at least one of these factors.

10.1371/journal.pone.0102589.t001

###### Baseline Characteristics of Participants and Deaths by 5 Categories of BMI Category.

![](pone.0102589.t001){#pone-0102589-t001-1}

  Variables                                            All     BMI (kg/m^2^)                                                            
  -------------------------------------------------- -------- --------------- ----- -------- ------ -------- ------ ------- ----- ----- -----
  Total                                               77,541       2,708       3.5   44,842   57.8   25,896   33.4   3,684   4.8   411   0.5
  Age (years)                                                                                                                           
  65--69                                              28,492        724        2.5   16,527   58.0   9,619    33.8   1,445   5.1   177   0.6
  70--74                                              18,381        524        2.9   10,212   55.6   6,549    35.6    967    5.3   129   0.7
  75--79                                              16,288        633        3,9   9,371    57.5   5,485    33.7    735    4.5   64    0.4
  80--84                                              9,888         466        4.7   5,941    60.1   3,054    30.9    391    4.0   36    0.4
  ≥85                                                 4,492         361        8.0   2,791    62.1   1,189    26.5    146    3.3    5    0.1
  Sex                                                                                                                                   
  Male                                                39,365       1,361       3.5   22.941   58.3   13,536   34.4   1,408   3.6   119   0.3
  Female                                              38,176       1,347       3.5   21,901   57.4   12,360   32.4   2,276   6.0   292   0.8
  Marital status                                                                                                                        
  Single                                              20,323        898        4.4   11,759   57.9   6,469    31.8   1,068   5.3   129   0.6
  Married/cohabiting                                  57,218       1,810       3.2   33,083   57.8   19,427   34.0   2,616   4.6   282   0.5
  Education (years)                                                                                                                     
  None                                                6,859         254        3.7   3,462    50.5   2,517    36.7    555    8.1   71    1.0
  1--6                                                21,492        697        3.2   11,408   53.1   7,848    36.5   1,378   6.4   161   0.8
  6--12                                               27,664        996        3.6   16,587   60.0   8,829    31.9   1,123   4.1   129   0.5
  ≥12                                                 21,526        761        3.5   13,385   62.2   6,702    31.1    628    2.9   50    0.2
  Smoking                                                                                                                               
  Frequently/occasionally                             6,849         348        5.1   4,003    58.5   2,199    32.1    273    4.0   26    0.4
  None                                                70,692       2,360       3.3   40,839   57.8   23,697   33.5   3,411   4.8   385   0.5
  Alcohol consumption                                                                                                                   
  Frequently/occasionally                             62,420        383        2.5   8,441    55.8   5,641    37.3    598    4.0   58    0.4
  None                                                15,121       2,325       3.7   36,401   58.3   20,255   32.5   3,086   4.9   353   0.6
  Regular exercise                                                                                                                      
  None                                                8,487         411        4.8   4,454    52.5   2,901    34.2    620    7.3   101   1.2
  1--2 times/week                                     28,780       1,039       3.6   16,367   56.9   9,717    33.8   1,461   5.1   196   0.7
  3--5 times/week                                     40,274       1,258       3.1   24,021   59.6   13,278   33.0   1,603   4.0   114   0.3
  High FBS (≥126 mg/dL)                                                                                                                 
  Yes                                                 9,923         117        1.2   4,770    48.1   4,043    40.7    868    8.8   125   1.3
  No                                                  67,618       2,591       3.8   40,072   59.3   21,853   32.3   2,816   4.2   286   0.4
  High SBP (≥140 mmHg)                                                                                                                  
  Yes                                                 30,745        817        2.7   16,387   53.3   11,429   37.2   1,884   6.1   228   0.7
  No                                                  46,796       1,891       4.0   28,455   60.8   14,467   30.9   1,800   3.9   183   0.4
  High TG (≥200 mg/dL)                                                                                                                  
  Yes                                                 9,349         50         0.5   4,345    46.5   4,152    44.4    722    7.7   80    0.9
  No                                                  68,192       2,658       3.9   40,497   59.4   21,744   31.9   2,962   4.3   331   0.5
  High TC (≥200 mg/dL)                                                                                                                  
  Yes                                                 36,919       1,153       3.1   21,576   58.4   12,240   33.2   1,740   4.7   210   0.6
  No                                                  40,622       1,555       3.8   23,266   57.3   13,656   33.6   1,944   4.8   201   0.5
  No risk factors[\*](#nt102){ref-type="table-fn"}    20,375       1,047       5.1   12,634   62.0   5,948    29.2    693    3.4   53    0.3
  1 factor                                            33,232       1,217       3.7   19,851   59.7   10,652   32.1   1,355   4.1   157   0.5
  2 factors                                           18,787        416        2.2   10,105   53.8   6,993    37.2   1,141   6.1   132   0.7
  3--4 factors                                        5,147         28         0.5   2,252    43.8   2,303    44.7    495    9.6   69    1.3
  All-cause mortality                                 3,842         341        8.9   2,310    60.1   1,032    26.9    135    3.5   24    0.6
  CVD-related mortality                                877          72         8.2    527     60.1    242     27.6    28     3.2    8    0.9
  Expanded CVD-related mortality                      1,116         91         8.2    655     58.7    323     28.9    37     3.3   10    0.9

BMI: body mass index; CVD: cardiovascular diseases; FBS: fasting blood sugar; SBP: systolic blood pressure; TG: triglycerides; TC: total cholesterol.

\*Factors included high FBS (i.e., ≥126 mg/dL), SBP (i.e., ≥140 mmHg), TG (≥200 mg/dL), and TC (≥200 mg/dL).

The clinical characteristics of each BMI category are presented in [Table 2](#pone-0102589-t002){ref-type="table"}. The composition factors related to metabolic syndrome, including FBS, SBP, diastolic BP, and TG, were significantly higher with higher BMI (for FBS, *P*\<0.001; for SBP, *P*\<0.001; for diastolic BP, *P*\<0.001; and for TG, *P*\<0.001). Other laboratory data including glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), albumin, blood urine nitrogen (BUN), creatinine, and hemoglobin also showed an association with BMI as the factors related to metabolic syndrome (for GOT, *P*\<0.001; for GPT, *P*\<0.001; for albumin, *P*\<0.001; for BUN, *P*\<0.001; for creatinine, *P*\<0.001; and for hemoglobin, *P*\<0.001).

10.1371/journal.pone.0102589.t002

###### Clinical Characteristics of Participants According to the BMI Category.

![](pone.0102589.t002){#pone-0102589-t002-2}

  Variables                             All       BMI (kg/m^2^)                                         
  --------------------------------- ------------ --------------- ------------ ------------ ------------ ------------
  Fasting blood sugar (mg/dL)        106.0±27.8     96.7±19.7     103.9±26.8   109.0±28.4   115.4±32.8   122.3±39.9
  Systolic blood pressure (mmHg)     135.3±19.7    129.2±20.9     133.8±19.7   137.7±19.0   141.0±19.3   143.9±22.4
  Diastolic blood pressure (mmHg)    76.2±11.7      72.3±12.1     75.2±11.5    77.8±11.6    79.2±11.9    81.1±14.0
  Triglyceride (mg/dL)               126.8±85.0     81.9±44.5     118.6±82.9   141.8±87.3   152.3±89.7   155.9±78.3
  Total cholesterol (mg/dL)           199±36.7     194.8±35.5     199.4±36.3   198.8±37.1   198.9±37.6   202.0±39.8
  GOT (U/L)                          25.1±14.7      26.6±16.6     24.6±14.2    25.6±14.9    27.4±16.9    29.5±22.3
  GPT (U/L)                          23.4±19.7      20.0±17.1     21.8±18.7    25.6±20.5    28.9±23.6    30.3±25.8
  Albumin (g/dL)                      4.3±0.3        4.3±0.3       4.3±0.3      4.4±0.3      4.3±0.3      4.3±0.3
  BUN (mg/dL)                         17.6±6.4      17.3±6.2       17.4±6.4     17.8±6.3     18.4±8.1     18.5±6.5
  Creatinine (mg/dL)                  1.0±0.5        1.0±0.5       1.0±0.5      1.0±0.5      1.0±0.6      1.0±0.5
  Hemoglobin (g/dL)                   13.6±1.4      12.9±1.5       13.5±1.4     13.8±1.4     13.7±1.4     13.6±1.4

BMI: body mass index; GOT: glutamic oxaloacetic transaminase; GPT: glutamic pyruvic transaminase; BUN: blood urine nitrogen.

The HRs of all-cause, CVD, and expanded CVD mortality calculated separately in the first (i.e., adequately adjusted) and second (i.e., over-adjusted) models are shown in [Table 3](#pone-0102589-t003){ref-type="table"}. The predictors of mortality were generally similar between models. Underweight (all-cause mortality, HR: 1.92, 95% confidence interval \[CI\]: 1.71--2.15; CVD mortality, HR: 1.74, 95% CI: 1.36--2.23; expanded CVD mortality, HR: 1.77, 95% CI: 1.42--2.21) and grade 2--3 obesity (all-cause mortality, HR: 1.59, 95% CI: 1.06--2.38; CVD mortality, HR: 2.36, 95% CI: 1.17--4.76; expanded CVD mortality, HR: 2.22, 95% CI: 1.18--4.15) as well as older age, male sex, smoking, and high FBS were significant predictors of all-cause, CVD, and expanded CVD mortality. On the other hand, being married/cohabitating, higher education, alcohol consumption, more regular exercise, and high TC were inversely associated with mortality. The results of the sensitivity test with the Weibull model remain robust. The hazard ratios of non-CVD mortality (i.e., excluding those with CVD mortality) among each BMI category were also calculated, that is, underweight (HR: 1.97, 95% CI: 1.73--2.24), overweight (HR: 0.81, 95% CI: 0.74--0.88), grade 1 obesity (HR: 0.84, 95% CI: 0.69--1.03), and grade 2--3 obesity (HR: 1.36, 95% CI: 0.83--2.24).

10.1371/journal.pone.0102589.t003

###### Cox Proportional Model of Factors Associated with All-cause, CVD, and Expanded CVD Mortality.

![](pone.0102589.t003){#pone-0102589-t003-3}

  Variables                     All-cause mortality     CVD mortality     Expanded CVD mortality                                            
  ---------------------------- --------------------- ------------------- ------------------------ -------------------- -------------------- --------------------
  BMI (18.5--24.9)                     1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  15.0--18.4 (underweight)       1.92 (1.71--2.15)    1.95 (1.74--2.19)     1.74 (1.36--2.23)      1.79 (1.39--2.29)    1.77 (1.42--2.21)    1.89 (1.52--2.36)
  25--29.9 (overweight)          0.82 (0.76--0.88)    0.79 (0.74--0.85)     0.85 (0.73--0.99)      0.83 (0.71--0.97)    0.90 (0.79--1.03)    0.85 (0.74--0.97)
  30--34.9 (grade 1obesity)      0.82 (0.69--0.98)    0.78 (0.65--0.93)     0.75 (0.51--1.09)      0.71 (0.49--1.05)    0.77 (0.55--1.07)    0.69 (0.49--0.96)
  ≥35 (grade 2--3 obesity)       1.59 (1.06--2.38)    1.48 (0.99--2.21)     2.36 (1.17--4.76)      2.24 (1.11--4.52)    2.22 (1.18--4.15)    1.94 (1.03--3.63)
  Age (years) (65--69)                 1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  70--74                         1.58 (1.39--1.78)    1.55 (1.37--1.76)     1.71 (1.30--2.25)      1.69 (1.28--2.22)    1.82 (1.43--2.31)    1.78 (1.40--2.26)
  75--79                         2.65 (2.37--2.97)    2.58 (2.30--2.89)     3.34 (2.62--4.31)      3.27 (2.55--4.20)    3.34 (2.69--4.16)    3.23 (2.59--4.03)
  80--84                         4.33 (3.86--4.86)    4.19 (3.73--4.70)     5.22 (4.05--6.72)      5.07 (3.93--6.53)    5.23 (4.19--6.54)    5.06 (4.05--6.33)
  ≥85                            7.60 (6.74--8.58)    7.33 (6.49--8.28)    10.26 (7.90--13.33)     9.93 (7.64--12.92)   9.18 (7.26--11.59)   8.88 (7.02--11.24)
  Sex (Female)                         1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  Male                           2.08 (1.92--2.24)    1.97 (1.82--2.13)     1.71 (1.46--2.01)      1.68 (1.43--1.98)    1.68 (1.46--1.94)    1.64 (1.42--1.89)
  Marital status (single)              1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  Married/cohabiting             0.83 (0.77--0.89)    0.83 (0.78--0.89)     0.82 (0.70--0.94)      0.82 (0.71--0.94)    0.79 (0.69--0.89)    0.79 (0.69--0.90)
  Education (years) (None)             1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  1--6                           0.84 (0.75--0.93)    0.85 (0.76--0.94)     0.87 (0.70--1.09)      0.88 (0.70--1.10)    0.89 (0.73--1.08)    0.90 (0.74--1.09)
  6--12                          0.71 (0.64--0.79)    0.72 (0.65--0.80)     0.73 (0.59--0.92)      0.74 (0.59--0.93)    0.69 (0.57--0.84)    0.71 (0.58--0.86)
  ≥12                            0.56 (0.50--0.63)    0.57 (0.51--0.64)     0.63 (0.49--0.80)      0.64 (0.50--0.81)    0.60 (0.48--0.74)    0.61 (0.50--0.76)
  Smoking (None)                       1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  Frequently/occasionally        1.48 (1.34--1.63)    1.48 (1.35--1.63)     1.30 (1.04--1.61)      1.30 (1.05--1.62)    1.29 (1.06--1.57)    1.30 (1.07--1.57)
  Alcohol consumption (None)           1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  Frequently/occasionally        0.72 (0.65--0.78)    0.73 (0.66--0.80)     0.66 (0.54--0.81)      0.67 (0.55--0.82)    0.63 (0.53--0.76)    0.64 (0.54--0.77)
  Regular exercise (None)              1.00                 1.00                   1.00                   1.00                 1.00                 1.00
  1--2 times/week                0.68 (0.62--0.75)    0.69 (0.63--0.75)     0.72 (0.59--0.87)      0.72 (0.59--0.87)    0.71 (0.60--0.83)    0.71 (0.60--0.84)
  3--5 times/week                0.53 (0.49--0.58)    0.53 (0.49--0.58)     0.59 (0.49--0.72)      0.59 (0.49--0.72)    0.53 (0.45--0.63)    0.54 (0.46--0.64)
  High FBS (None)                                           1.00                                          1.00                                      1.00
  ≥126 mg/dL                                          1.44 (1.32--1.57)                            1.23 (1.02--1.48)                         1.80 (1.55--2.09)
  High SBP (None)                      1.00                                        1.00                                        1.00         
  ≥140 mmHg                                           1.04 (0.98--1.11)                            1.13 (0.99--1.29)                         1.11 (0.99--1.25)
  High TG (None)                                            1.00                                          1.00                                      1.00
  ≥200 mg/dL                                          1.02 (0.92--1.13)                            1.05 (0.85--1.30)                         1.18 (0.98--1.40)
  High TC (None)                                            1.00                                          1.00                                      1.00
  ≥200 mg/dL                                          0.77 (0.72--0.83)                            0.89 (0.77--1.02)                         0.84 (0.75--0.96)

Model 1: adjusted for age, sex, marital status, education level, smoking, alcohol consumption, and exercise status.

Model 2: adjusted for all factors in Model 1 plus high FBS, high SBP, high TG, and high TC.

BMI: body mass index; CVD: cardiovascular disease; FBS: fasting blood sugar; SBP: systolic blood pressure; TG: triglycerides; TC: total cholesterol.

A sensitivity test combining grades 1 and 2--3 obesity as a single obese group was performed. Compared to normal body weight, this obese group (i.e., BMI≥30) tended to have lower HRs for overall mortality (all-cause mortality, HR: 0.89, 95% CI: 0.75--1.04; CVD mortality, HR: 0.88, 95% CI: 0.63--1.23; expanded CVD mortality, HR: 0.89, 95% CI: 0.66--01.20). Another sensitivity test set the reference group as 23≤BMI\<25, and the results were also similar.

The associations of BMI with all-cause, CVD, and expanded CVD mortality among the elderly were all represented as generally similar asymmetric U-shaped curves with large flat bottoms and right curves that started to rise significantly at BMI≥35 ([Figure 1](#pone-0102589-g001){ref-type="fig"}). The HRs of overweight and grade 1 obesity shared a nadir on the all-cause mortality curve, and the HR of grade 1 obesity was at the nadirs of the CVD and expanded CVD curves. The effects of grade 2--3 obesity were more prominent on CVD and expanded CVD mortality than all-cause mortality.

![HRs for all-cause, CVD, and expanded CVD mortality according to BMI category.](pone.0102589.g001){#pone-0102589-g001}

Subgroup analyses are presented in [Figure 2](#pone-0102589-g002){ref-type="fig"}. The HRs were almost the same in subgroup analyses. Among smokers, grade 2--3 obesity was more strongly associated with the mortality (all-cause mortality, HR: 3.25, 95% CI: 1.33--7.93; CVD mortality, HR: 10.71, 95% CI: 3.23--35.44; expanded CVD mortality, HR: 7.86, 95% CI: 2.41--25.58). In the high TG group, underweight was strongly associated with mortality (all-cause mortality, HR: 5.82, 95% CI: 3.30--10.25; CVD mortality, HR: 10.99, 95% CI: 4.28--28.22; expanded CVD mortality, HR: 14.22, 95% CI: 7.18--28.17). Among those with 3--4 factors related to metabolic syndrome, underweight was significantly associated with mortality (all-cause mortality, HR: 4.86, 95% CI: 2.36--10.01; CVD mortality, HR: 12.72, 95% CI: 4.31--37.51; expanded CVD mortality, HR: 11.42, 95% CI: 4.73--27.58).

![Subgroup analysis of all-cause, CVD, and expanded CVD mortality.](pone.0102589.g002){#pone-0102589-g002}

Discussion {#s4}
==========

The results of this study show the association between measured BMI and mortality in the elderly. The large sample size enabled subgroup analysis according to particular characteristics. Relative to the normal weight category, the associations of BMI with all-cause, CVD, and expanded CVD mortality in the elderly were generally represented as U-shaped curves with large flat bottoms at overweight and grade 1 obesity, and a right curve that was significantly elevated at a BMI≥35.

The different effects of grades 1 and 2--3 obesity on mortality are noteworthy. When subjects with BMI≥30 were treated as a single obesity group, the overall HR indicated lower mortality; this is because mildly obese subjects outnumbered moderate--severe obese subjects. These results are broadly consistent with those of 3 meta-analyses, which report obesity is associated with lower mortality [@pone.0102589-Janssen1], [@pone.0102589-Flegal2], [@pone.0102589-McGee1]. However, treating different levels of obesity as a single group might obscure the heterogeneous effects of mild and moderate--severe obesity on mortality.

Some authors suggest lowering the BMI cut-offs for Asian populations [@pone.0102589-Wen1], while others disagree [@pone.0102589-Gu1]. Wen et al. report significant mortality risks starting at a BMI≥25 in a much younger Taiwanese cohort [@pone.0102589-Wen1]. Meanwhile, Gu et al. report underweight and obesity are associated with increased mortality in a Chinese adult population and support the use of a single common recommendation for defining overweight and obesity for all ethnicities [@pone.0102589-Gu1]. In the present study, the risks of mortality in an elderly Taiwanese population did not differ substantially from those of Western counterparts [@pone.0102589-Janssen1], [@pone.0102589-Flegal2], corroborating the use of a single common recommendation for defining overweight and obesity among all ethnic groups. Furthermore, these findings corroborate the notion that overweight and mild obesity are relatively less harmful in the elderly.

Underweight was associated with increased mortality in previous studies [@pone.0102589-Flegal4]--[@pone.0102589-Wang1]. In the present study, underweight was associated with all-cause, CVD, and expanded CVD mortality in the elderly. These effects persisted in subgroup analysis. Accordingly, some studies suggest modestly higher body weight may improve survival in some circumstances [@pone.0102589-Artham1]--[@pone.0102589-Uretsky1]. Indeed, overweight and grade 1 obesity were associated with lower mortality risks in the present study, suggesting slightly or mildly elevated BMI increases survival in the elderly. There are some possible explanations for this phenomenon. First, fat storage might be a protective resource in some individuals exposed to acute insults or chronic wasting [@pone.0102589-Doehner1]. Second, BMI cannot distinguish excess body fat from increased lean mass [@pone.0102589-Heymsfield1]. Third, obesity patients may present with symptoms and morbidities earlier [@pone.0102589-Oreopoulos1], making them more likely to receive prompt medical treatment [@pone.0102589-Schenkeveld1].

Nevertheless, the observed decrease in mortality risk reverses beyond mild obesity. In particular, grade 2--3 obesity was associated with increased risks of all-cause, CVD, and expanded CVD mortality. These results are consistent with those of a previous study, reporting moderate obesity is associated with an increased risk of mortality [@pone.0102589-Janssen1]. Therefore, the present findings may have important implications contrary to the current clinical recommendation that overweight and mildly obese elderly people should lose weight.

In previous studies investigating the association between BMI and mortality, models were considered adequate if adjusted for age, sex, and smoking. Models adjusting for additional factors such as hypertension are considered possibly over-adjusted, because such factors are considered to be a part of the causal relationship between obesity and mortality [@pone.0102589-Flegal2]. Therefore, in order to test the predictive capability of BMI for mortality rather than inferring a causal relationship, evaluating other factors as potential confounders is not a large concern. Regardless, in the present study, the results of the adequately adjusted and over-adjusted models were not substantially different.

Smoking is considered an important risk factor for morbidity and mortality, particularly CVD mortality. Previous studies have analyzed the association between BMI and mortality among non-smokers to avoid the confounding effect of smoking [@pone.0102589-Tsai1]. In the present subgroup analysis, the results of non-smokers were similar to those of the total population. However, it is worth noting the HRs of smokers increased sharply in grade 2--3 obesity, for especially CVD and expanded CVD mortality. The excess mortality risks of BMI among smokers suggest smoking enhances the relationship between higher BMI and survival in the elderly [@pone.0102589-Whitlock1].

Diabetes is one of the most significant risk factors for CVD, and BMI is strongly associated with an increased prevalence of CVD independent of metabolic syndrome [@pone.0102589-He1]. In the present study, high FBS was significantly associated with all-cause, CVD, and expanded CVD mortality, whereas high SBP and TG were not. Most interestingly, high TC was negatively associated with mortality, which has been reported previously [@pone.0102589-Akerblom1], [@pone.0102589-Schupf1]. In the present study, high TC was associated with higher BMI. Therefore, high TC is possibly associated with better global health conditions among the elderly population. However, the actual role of hypercholesterolemia as a risk factor for mortality among the elderly requires further investigation.

The present study has several limitations. First, this study did not consider preexisting diseases or therapeutic regimens used to control diabetes, hypertension, or dyslipidemia. Baseline laboratory data were used for adjustment in the models and subgroup analysis. Moreover, reverse causation and illness-related weight loss could confound the association between BMI and mortality [@pone.0102589-Flegal5]. A sensitivity test to set the reference group as subjects with a BMI from 23--24.9, which would exclude people who might be underweight due to underlying diseases, would partially reduce the impact of preexisting diseases as the cause of death. Regardless, residual confounding or reverse causation due to preexisting illnesses is reported to have little effect on the estimated relative risks of mortality [@pone.0102589-Greenberg1], [@pone.0102589-Flegal6]. Second, the baseline examination data were used to represent all participants in the cohort. These data may have changed over time, leading to complex effects on mortality rates. However, the present results demonstrate the power of a single determination of BMI for predicting mortality risk. Third, the present study analyzed the statistical association between BMI and mortality. Several other factors associated with weight and mortality, such as physical activity level and body composition, could be responsible for part of the observed association. Therefore, mortality data from well-controlled weight loss trials are required to clarify the association between BMI and mortality. Fourth, the voluntary participants of this study may not be representative of the general population. However, because risk comparison was based on internal comparison, the calculated relative risks are a reasonable estimate of those in the general population.

In conclusion, the U-shaped relationship between BMI and mortality in the elderly in the present study suggests unilateral promotions or interventions in weight reduction in the elderly may be inappropriate. Thus, losing weight may not be uniformly beneficial to the health of elderly persons. In particular, it might be necessary to reevaluate strategies related to the pertinence of lowering the weight of those overweight and grade 1 obesity elderly patients.
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